Piracetam vs Noopept: Comparing Two Popular Nootropics

Quick Answer: Piracetam vs Noopept (Omberacetam)

Piracetam is the original racetam nootropic with over 50 years of clinical data, taken at 2,400 to 4,800 mg/day. Noopept is a synthetic peptide-derived compound approximately 1,000 times more potent by weight, dosed at 10 to 30 mg/day. Piracetam enhances cholinergic transmission and cerebral blood flow. Noopept modulates glutamate receptors and increases BDNF and NGF. Piracetam has the stronger safety record. Noopept has faster onset and lower dose requirements.

How They Work: Mechanism Comparison

Piracetam modulates AMPA receptors, enhances cholinergic neurotransmission by increasing acetylcholine turnover in the hippocampus, and improves cerebral blood flow and neuronal membrane fluidity. Its effects build gradually over days to weeks of consistent dosing. Noopept (GVS-111/omberacetam) is a dipeptide analog of piracetam that acts on AMPA and NMDA glutamate receptors. It also increases brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), which support neuronal survival and synaptic plasticity. Noopept crosses the blood-brain barrier more efficiently than piracetam, which explains its much lower effective dose.

Head-to-Head Comparison

Factor Piracetam Noopept
Compound Class Racetam (2-pyrrolidone derivative) Peptide-derived (dipeptide analog of piracetam)
Dosage 2,400 to 4,800 mg/day (2 to 4 tablets) 10 to 30 mg/day (sublingual or oral)
Potency (by weight) Baseline Approximately 1,000x more potent
Primary Mechanism Cholinergic enhancement, AMPA modulation Glutamate (AMPA/NMDA) modulation, BDNF/NGF increase
Onset Gradual (days to weeks for full effect) Rapid (effects within 15 to 20 minutes)
Clinical Evidence 50+ years, Cochrane reviews, 24+ RCTs Limited: primarily Russian clinical studies
Safety Profile Excellent (LD50 >10 g/kg, minimal adverse events) Good but less long-term data available
Choline Demand High (choline supplementation recommended) Low to moderate
Legal Status (Canada) Not controlled, available for research Not controlled, available for research

Clinical Evidence

Piracetam has been studied in over 24 randomized controlled trials and was the subject of a 2005 Cochrane review (Flicker and Grimley Evans) which found evidence of cognitive improvement in age-related decline. Its safety is well-established with an LD50 exceeding 10 g/kg. Noopept was developed at the Russian Academy of Sciences and approved in Russia as a nootropic drug. A 2009 study by Ostrovskaya et al. demonstrated cognitive enhancement in animal models at 0.5 to 1 mg/kg, and human trials in Russia reported improvements in attention and memory at 10 mg three times daily. However, Noopept has not been evaluated in Cochrane reviews or large Western RCTs.

Who Should Choose Piracetam?

Piracetam is ideal for researchers seeking a well-studied compound with decades of safety data. It is preferred for long-term cognitive support protocols, age-related cognitive decline research, and studies where a large body of reference literature is important. Its gradual onset and broad mechanism make it suitable for sustained use.

Who Should Choose Noopept?

Noopept is chosen by researchers seeking acute cognitive effects at very low doses, those studying neurotrophic factors (BDNF/NGF), and those who prefer sublingual administration. Its rapid onset makes it popular for studying short-term cognitive enhancement. However, the limited Western clinical data means less reference literature is available.

How to Source Piracetam in Canada

Elite Bio Supply carries pharmaceutical-grade Piracetam (1200 mg tablets, 100-count) with domestic shipping across Canada via Canada Post. All products are third-party tested for purity and identity. View Piracetam product page and order.

Related Guides

Order Piracetam (1200 mg tablets, 100-count)

View Product and Order

Shipped from Canada. Discreet packaging. 350+ cryptocurrencies accepted.

Elite Bio Supply sells research compounds for research purposes only. This content does not constitute medical advice. The comparison above is based on published clinical literature and is provided for informational purposes. Consult a qualified physician before starting any protocol.

Get notified about new products and research

No spam. Just new arrivals, restocks, and articles like this one.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top
ENFR